INTRODUCTION: Heart rate slowing agents are frequently prescribed to manage heart transplant (HTx) patients with the assumption that higher heart rate is a risk factor in cardiovascular disease. PATIENTS AND METHODS: This prospective two-center study investigated early progression of cardiac allograft vasculopathy (CAV) in 116 HTx patients. Examinations by coronary optical coherence tomography and 24-hour ambulatory ECG monitoring were performed both at baseline (1 month after HTx) and during follow-up (12 months after HTx). RESULTS: During the first post-HTx year, we observed a significant reduction in the mean coronary luminal area from 9.0 ± 2.5 to 8.0 ± 2.4 mm2 (P < .001), and progression in mean intimal thickness (IT) from 106.5 ± 40.4 to 130.1 ± 53.0 µm (P < .001). No significant relationship was observed between baseline and follow-up mean heart rates and IT progression (R = .02, P = .83; R = -.13, P = .18). We found a mild inverse association between beta-blocker dosage at 12 months and IT progression (R = -.20, P = .035). CONCLUSION: Our study did not confirm a direct association between mean heart rate and progression of CAV. The role of beta blockers warrants further investigation, with our results indicating that they may play a protective role in early CAV development.

2nd Department of Internal Medicine Department of Cardiovascular Medicine 1st Faculty of Medicine Charles University Prague and General University Hospital Prague Prague Czech Republic

Cardiovascular and Transplantation Surgery Brno Czech Republic

Department of Cardiology 2nd Medical School Charles University University Hospital Motol Prague Czech Republic

Department of Cardiology IKEM Prague Czech Republic

Department of Cardiovascular Diseases St Anne's University Hospital and Masaryk University Brno Brno Czech Republic

Iowa Institute for Biomedical Imaging The University of Iowa Iowa City IA USA

Zobrazit více v PubMed

Sekar B, Critchley WR, Williams SG, et al. Should we consider heart rate reduction in cardiac transplant recipients? Clin Cardiol. 2013. February;36(2):68–73. PubMed PMC

Palatini P, Thijs L, Staessen JA, et al. Predictive value of clinic and ambulatory heart rate for mortality in elderly subjects with systolic hypertension. Arch Intern Med. 2002;162(20):2313–2321. PubMed

Cooney MT, Vartiainen E, Laatikainen T, et al. Elevated resting heart rate is an independent risk factor for cardiovascular disease in healthy men and women. Am Heart J. 2010;159(4):612–619.e3. PubMed

Fox K, Borer JS, Camm AJ, et al. Resting heart rate in cardiovascular disease. J Am Coll Cardiol. 2007;50(9):823–830. PubMed

Ciarka A, Lund LH, Van Cleemput J, et al. Effect of heart rate and use of beta blockers on mortality after heart transplantation. Am J Cardiol. 2016;118(12):1916–1921. PubMed

Giannoglou GD, Chatzizisis YS, Zamboulis C, et al. Elevated heart rate and atherosclerosis: an overview of the pathogenetic mechanisms. Int J Cardiol. 2008;126(3):302–312. PubMed

Ambrosi P, Kreitmann B, Habib G. Does heart rate predict allograft vasculopathy in heart transplant recipients? Int J Cardiol. 2010;145(2):256–257. PubMed

Gullestad L, Ross H, Myers J, et al. Importance of decreased heart rate in predicting transplant coronary artery disease. Clin Transplant. 1997;11(6):628–632. PubMed

Olmetti F, Pinna GD, Maestri R, et al. Heart rate and cardiac allograft vasculopathy in heart transplant recipients. J Heart Lung Transplant. 2011;30(12):1368–1373. PubMed

Liebo M, Newman J, Joshi A, et al. Elevated heart rate following heart transplantation is associated with increased graft vasculopathy and mortality. J Card Fail. 2019. April;25(4):249–256. PubMed

Abraham WT. Switching to evidence-based once-daily beta-blockers for improved adherence to medication across the continuum of post-myocardial infarction left ventricular dysfunction and heart failure. Congest Heart Fail. 2008;14(5):272–280. PubMed

Lee K, Zhang L, Abramoff MD, et al. Fast and memory efficient LOGISMOS graph search for intraretinal layer segmentation of 3D macular OCT scans. Proc SPIE. 2015;9413:94133X/1–6.

Zhang H, Abiose AK, Gupta D, et al. Novel indices for left-ventricular dyssynchrony characterization based on highly automated segmentation from real-time 3-D echocardiography. Ultrasound Med Biol. 2013;39(1):72–88. PubMed PMC

Chen Z, Pazdernik M, Zhang H, et al. Quantitative 3D analysis of coronary wall morphology in heart transplant patients: OCT-assessed cardiac allograft vasculopathy progression. Med Image Anal. 2018;50:95–105. PubMed PMC

Pazdernik M, Chen Z, Bedanova H, et al. Early detection of cardiac allograft vasculopathy using highly automated 3-dimensional optical coherence tomography analysis. J Heart Lung Transplant. 2018;37(8):992–1000. PubMed

Sun S, Sonka M, Beichel RR. Graph-based IVUS segmentation with efficient computer-aided refinement. IEEE Trans Med Imaging. 2013;32(8):1536–1549. PubMed PMC

Chen Z Novel quantitative description approaches assessing coronary morphology and development (PhD thesis). Iowa City, IA: University of Iowa; 2016.

Clemmensen TS, Holm NR, Eiskjær H, et al. Detection of early changes in the coronary artery microstructure after heart transplantation: A prospective optical coherence tomography study. J Heart Lung Transplant. 2017;37(4):486–495. PubMed

Matsuo Y, Cassar A, Yoshino S, et al. Attenuation of cardiac allograft vasculopathy by sirolimus: Relationship to time interval after heart transplantation. J Heart Lung Transplant. 2013;32(8):784–91. PubMed PMC

Ghafourian K, Kobashigawa JA. Slowing sinus tachycardia in heart transplant recipients: Is it time? Rev Esp Cardiol (Engl Ed). 2015;68(11):921–923. PubMed

Tsutsui H, Ziada KM, Schoenhagen P, et al. Lumen loss in transplant coronary artery disease is a biphasic process involving early intimal thickening and late constrictive remodeling: Results from a 5-year serial intravascular ultrasound study. Circulation. 2001;104(6):653–657. PubMed

Chih S, Chong AY, Mielniczuk LM, et al. Allograft vasculopathy: The Achilles’ heel of heart transplantation. J Am Coll Cardiol. 2016;68(1):80–91. PubMed

Khandhar SJ, Yamamoto H, Teuteberg JJ, et al. Optical coherence tomography for characterization of cardiac allograft vasculopathy after heart transplantation (OCTCAV Study). J Heart Lung Transplant. 2013;32(6):596–602. PubMed

Cassar A, Matsuo Y, Herrmann J, et al. Coronary atherosclerosis with vulnerable plaque and complicated lesions in transplant recipients: New insight into cardiac allograft vasculopathy by optical coherence tomography. Eur Heart J. 2013;34(33):2610–2617. PubMed PMC

Castel MA, Roig E, Rios J, et al. Long-term prognostic value of elevated heart rate one year after heart transplantation. Int J Cardiol. 2013;168(3):2003–2007. PubMed

Wachter SB, McCandless SP, Gilbert EM, et al. Elevated resting heart rate in heart transplant recipients: innocent bystander or adverse prognostic indicator? Clin Transplant. 2015;29(9):829–834. PubMed

Bedanova H, Fila P, Horvath V, et al. Association between the heart rate early after heart transplantation and the long-term clinical outcomes. Bratisl Lek Listy. 2017;118(6):366–369. PubMed

Awad M, Czer LS, Hou M, et al. Early denervation and later reinnervation of the heart following cardiac transplantation: A review. J Am Heart Assoc. 2016;5(11):e004070. PubMed PMC

Moghtadaei M, Jansen HJ, Mackasey MJ, et al. The impacts of age and frailty on heart rate and sinoatrial node function. J Physiol. 2016;594(23):7105–7126. PubMed PMC

Verani MS, Nishimura S, Mahmarian JJ, et al. Cardiac function after orthotopic heart transplantation: response to postural changes, exercise, and beta-adrenergic blockade. J Heart Lung Transplant. 1994;13(2):181–193. PubMed

Padilla J, Young CN, Simmons GH, et al. Increased muscle sympathetic nerve activity acutely alters conduit artery shear rate patterns. Am J Physiol Heart Circ Physiol. 2010;298(4):H1128–H1135. PubMed PMC